BioSpace News Archive

Policy

Struggling Teva Gets Another Hit, Fined for Foreign Bribes

The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said.

January 15, 2018
·
1 min read
Hua Medicine to Raise $200M to Support Novel Diabetes Drug

Hua Medicine of Shanghai expects to spend $200M over the next three years on its novel oral diabetes 2 treatment, dorzagliatin.

January 15, 2018
·
1 min read
Suzhou Kintor Raises $44M for Novel Drug Portfolio

Suzhou Kintor Pharma raised $44M in a funding led by Shenzhen Green Pine Capital Partners.

January 15, 2018
·
1 min read
Biotech Bay

3 Biopharmas Worth Watching in 2018

Here are three biopharma stocks worth keeping an eye on.

January 15, 2018
·
2 min read
·
Mark Terry
Deals

5 Tasty Takeover Targets for 2018

Many investors and analysts expect that the changes to the corporate tax code will lead to increased merger and acquisition activity in 2018.

January 15, 2018
·
3 min read
·
Mark Terry
FDA

BD, Check-Points Win CE Mark for Next-Generation Resistant Bacteria Screening Test

The new test provides diagnostic results up to 10 times faster than traditional tests.

January 15, 2018
·
5 min read
Policy

Radient Technologies Inc. Reiterates its Non-Exposure to U.S. Marijuna-Related Activity

Within its cannabinoid-focused lines of business, Radient has continued to recognize the authority of the U.S. Department of Justice to enforce laws related to marijuana, and that government policy could at any time revoke or change prior guidance relating to these laws.

January 15, 2018
·
3 min read
Avivagen Announces Positive Results From Swine Trial

Results from the independent study demonstrated that OxC-beta not only benefited sow health but also led to improvements in the health of nursing piglets.

January 15, 2018
·
6 min read
Pharm Country

Creative Peptides Added New GLP-1 Peptides for Diabetes Research

On January 11, 2018, the leading peptide expert Creative Peptides announced to add new GLP-1 peptides targeting for diabetes research.

January 15, 2018
·
2 min read
Business

Netherlands Cancer Institute Grants Exclusive License to Desktop Genetics for TIDE

The TIDE technology will allow investigators to quantitatively assess genome editing on the DESKGEN Cloud, the free CRISPR design software from DTG.

January 15, 2018
·
2 min read